Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer

被引:77
|
作者
D'Amico, AV
Wu, YH
Chen, MH
Nash, M
Renshaw, AA
Richie, JP
机构
[1] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[3] Brigham & Womens Hosp, Dept Urol, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Boston, MA 02115 USA
[5] Worcester Polytech Inst, Dept Math Sci, Worcester, MA 01609 USA
来源
JOURNAL OF UROLOGY | 2001年 / 165卷 / 01期
关键词
prostatic neoplasms; prostate-specific antigen; prostatectomy; outcome and process assessment (health care);
D O I
10.1097/00005392-200101000-00031
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: The presence of perineural invasion on the prostate needle biopsy specimen has been suggested to be an independent predictor of prostate specific antigen (PSA) outcome following radical prostatectomy. We evaluated the clinical use of perineural invasion at biopsy for predicting time to PSA failure following radical prostatectomy after controlling for established prognostic factors. Materials and Methods: A prospective evaluation using a Cox regression multivariate analysis of 750 men with clinically localized or PSA detected prostate cancer was performed to evaluate the ability of PSA, biopsy Gleason score, perineural invasion on the needle biopsy specimen and the percent of positive prostate biopsies to predict PSA outcome following radical prostatectomy. Results: Multivariate analysis demonstrated that the presence of perineural invasion on the needle biopsy specimen provided additional information regarding 5-year PSA outcome (82% versus 95%, p = 0.04) for patients who were in the low risk group. This difference in PSA outcome could be explained by higher rates of positive surgical margins (25% versus 17%, p = 0.07). Patients whose prostate needle biopsy contained perineural invasion and who had the corresponding neurovascular bundle resected had a significantly lower positive margin rate (11% versus 100%, p = 0.001) compared to those who had the neurovascular bundle spared. The presence of perineural invasion on biopsy was not a significant predictor of PSA outcome following radical prostatectomy for patients in the intermediate or high risk group. Conclusions: Resection of the neurovascular bundle on the side corresponding to location of perineural invasion on the biopsy may decrease the positive surgical margin rate and improve outcome for low risk patients.
引用
收藏
页码:126 / 129
页数:4
相关论文
共 50 条
  • [21] Radical prostatectomy in younger men (age <60) with clinically localized prostate cancer
    Chang, Peter
    Tewari, Ashutosh K.
    Raman, Jay D.
    Rao, Sandhya
    Divine, George
    Menon, Mani
    JOURNAL OF UROLOGY, 2007, 177 (04): : 530 - 530
  • [22] Captopril may reduce biochemical (prostate-specific antigen) failure following radical prostatectomy for clinically localized prostate cancer
    Ronquist, Gunnar
    Frithz, Goran
    Wang, Yu-Hui
    Lindeborg, Torsten
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 2009, 43 (01): : 32 - 36
  • [23] INTERMEDIATE TO LONG-TERM ONCOLOGIC OUTCOME FOLLOWING LAPAROSCOPIC RADICAL PROSTATECTOMY FOR CLINICALLY LOCALIZED PROSTATE CANCER
    Mortezavi, A.
    Baumgartner, M.
    Hermanns, T.
    Sulser, T.
    Seifert, H.
    JOURNAL OF ENDOUROLOGY, 2009, 23 : A188 - A188
  • [24] Immunohistochemical expression of Bcl2 is an independent predictor of time-to-biochemical failure in patients with clinically localized prostate cancer following radical prostatectomy
    Revelos, K
    Petraki, C
    Gregorakis, A
    Scorilas, A
    Papanastasiou, P
    Koutsilieris, M
    ANTICANCER RESEARCH, 2005, 25 (04) : 3123 - 3133
  • [25] Is radical prostatectomy of benefit in men with localized prostate cancer?
    Shomik Sengupta
    Horst Zincke
    Nature Clinical Practice Oncology, 2005, 2 : 608 - 609
  • [26] Is radical prostatectomy of benefit in men with localized prostate cancer?
    Sengupta, S
    Zincke, H
    NATURE CLINICAL PRACTICE ONCOLOGY, 2005, 2 (12): : 608 - 609
  • [27] Clinical utility of the percentage of positive prostate biopsies in defining biochemical outcome after radical prostatectomy for patients with clinically localized prostate cancer
    D'Amico, AV
    Whittington, R
    Malkowicz, SB
    Schultz, D
    Fondurulia, J
    Chen, MH
    Tomaszewski, JE
    Renshaw, AA
    Wein, A
    Richie, JP
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) : 1164 - 1172
  • [28] Prostatectomy and survival among men with clinically localized prostate cancer
    Lawrence, G
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (21): : 1724 - 1724
  • [29] Is year of radical prostatectomy a predictor of outcome in prostate cancer?
    Cagiannos, I
    Karakiewicz, P
    Graefen, M
    Eastham, JA
    Ohori, M
    Rabbani, F
    Reuter, V
    Wheeler, T
    Kupelian, P
    Klein, E
    Huland, H
    Hammerer, PG
    Erbersdobler, A
    Schroeder, F
    Wildhagen, M
    Quinn, DI
    Henshall, SM
    Grygiel, JJ
    Sutherland, RL
    Stricker, PD
    Morash, CG
    Scardino, PT
    Kattan, MW
    JOURNAL OF UROLOGY, 2004, 171 (02): : 692 - 696
  • [30] Biochemical Outcome after Radical Prostatectomy for High-Risk Localized Prostate Cancer
    Roder, M.
    Berg, K.
    Christensen, I
    Gruschy, L.
    Brasso, K.
    Iversen, P.
    UROLOGY, 2012, 80 (03) : S32 - S32